NCT01520272View on ClinicalTrials.gov

HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda

CompletedOBSERVATIONAL
Enrollment

376

Participants

Timeline

Start Date

January 2, 2012

Study Completion Date

June 28, 2017

Conditions
HPV16 Anitbody Levels Post VaccinationHPV18 Antibody Levels Post Vaccination
Trial Locations (1)

Unknown

District of Nakasangola, Kampala

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01520272 - HPV Vaccine Effectiveness in Partially Vaccinated Girls in Uganda | Biotech Hunter | Biotech Hunter